University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 15 of 23
Thenar Tissue Oxygen Concentration (StO2): A Non-invasive Surrogate for Central Venous Oxygen Saturation (ScvO2)
NCT02476630
Mobile Health (mHealth) Black Women With Breast Cancer
NCT02463474
NEPAL (Neuromodulatory Examination of Pain and Mobility Across the Lifespan)
NCT02488863
Implementation of Comprehensive Stroke Rehabilitation Therapy for Enhanced Quality of Life
NCT02225990
iCare for Cancer Patients
NCT02435550
Angiotensin Converting Enzyme (ACE2), Brain, Gut Dysbiosis in Pulmonary Hypertension
NCT04104490
In Vivo Imaging of Therapeutic Electric Current Flow
NCT02453763
Acute Vascular Response to Exercise in Women With Nonobstructive Coronary Artery Disease
NCT02450318
Acute Effect of Exercise on Vascular Function
NCT02408614
Implementing Genomics in Practice (IGNITE) Proof of Concept Study: Genotyping in Family Medicine Clinics
NCT02335307
The Effects of a High Protein Diet on Microbiota, Gastrointestinal Function and Wellness in Older Women
NCT02445560
Long Term Cognitive Impact of Pediatric Acute Renal Injury
NCT02372734
Strength Training in Duchenne Muscular Dystrophy
NCT02421523
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
NCT03277768
Persistent Post-Surgical Pain in Women With BrCA
NCT02266082
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
NCT02398708
Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
NCT02393001
Transcranial Magnetic Stimulation for Treatment of Insomnia
NCT02196025
Music in the Emergency Department (ED): Phase II
NCT02363179
Effects of Adding Chickpeas to the American Diet (Long Term Study)
NCT02375373
Relationship of Mitochondrial Enzymes With Cancer Related Fatigue
NCT02414971
Healthcare Text Messaging to Improve Diet, Physical Activity and Weight Loss in a Pediatric Lipid Clinic
NCT02228278
Cough According to Stimulus Type in PD
NCT02390089
Dynamic Respiratory Muscle Function in Late-Onset Pompe Disease
NCT02354664
Cough in Reduced True Vocal Fold Mobility
NCT02407301
Transcranial Doppler Ultrasound Monitoring During Flow-Diverter Embolization
NCT02354300
Airway Muscle Training for Obstructive Sleep Apnea
NCT02259660
Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy
NCT02404818
CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients
NCT02139072
Effects of Adding Chickpeas to the American Diet on Fecal Microbiota Composition and Markers of Inflammation
NCT02375347
Oxytocin Trial in Prader-Willi Syndrome
NCT02013258
Oral Alkali Production and Caries Prevention in Children (Cross-sectional Component)
NCT02368028
Health Behaviors and Time-of-Day: Older Adult Cognitive Function
NCT02300272
Project 4A: Inspiratory Muscle Training and Diaphragm Strength
NCT02367170
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant
NCT02326675
The Effect of Exercise on Neurorecovery Following Mild Traumatic Brain Injury
NCT02276079
rTMS and Botulinum Toxin in Benign Essential Blepharospasm
NCT02370875
Treatment of Feeding Problems in Children With Autism
NCT02275715
Circulating Tumor Cells in Operative Blood
NCT02150746
The Role of Dysfunctional HDL in Severe Sepsis
NCT02370186
Feasibility Assessment of Neurophysiological Measurement in Veterans With LBP
NCT02375386
Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS
NCT02276066
Neuromodulation of Cognition in Older Adults
NCT02137122
A New Method for Detection of Bacteria in the Bloodstream
NCT02323165
Point of Care Testing of Inflammatory Markers in Tears
NCT02315079
Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies
NCT02349711
A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease
NCT02318927
Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
NCT02287909
Histamine Glutamate Antagonism in Stroke
NCT02142712
Neurotoxin and Physical Therapy
NCT02177617
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.